How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxicity?

PARTIALLY ADDRESSED

Both theorist and domain expert acknowledged that existing epigenetic modulators cause significant off-target effects when used systemically. The debate did not resolve how to achieve brain-specific targeting or identify which specific isoforms are critical in microglia. Source: Debate session sess_SDA-2026-04-04-gap-20260404-microglial-priming-early-ad (Analysis: SDA-2026-04-04-gap-20260404-microglial-priming-early-ad)

Priority: 0.78 Domain: pharmacology Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxicity? is a 0.78 priority gap in pharmacology. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How can CNS-selective HDAC/DNMT inhibitors be developed to avoid systemic toxicity? — INVOKE-2 (completed)

📈 Living Dashboards

0

Hypotheses

0.000

Top Score

0.000

Avg Score

0

Debates

0.00

Avg Quality

60%

Resolution

0

Mechanistic Families

Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (9)

HDAC→MsHDAC→AnxietyHDAC→DepressionHDAC→ParkinsonHDAC→Autoimmune

▸ Show 4 more

HDAC→CardiovascularHDAC→DiabetesHDAC→AlsHDAC→Carcinoma

associated with (7)

ALZHEIMER'S DISEASE→HDACTNF→HDACIL-6→HDACHDAC→AlsHDAC→ALS

▸ Show 2 more

HDAC→Amyotrophic Lateral SclerosisHDAC→Ms

causes (1)

HDAC→Neurodegeneration

contributes to (1)

HDAC→Neurodegeneration

expressed in (2)

HDAC→cortexHDAC→Ms

implicated in (1)

HDAC→Inflammation

inhibits (13)

5-azacytidine→DNMTdecitabine→DNMTALZHEIMER'S DISEASE→HDACHDAC→Alzheimer's diseaseSCFA→HDAC

▸ Show 8 more

HDAC→neural stem cellsHDAC→agingButyrate→HDACHDAC→NeurodegenerationHDAC→AlsHDAC→NeuroinflammationHDAC→ParkinsonHDAC→Autoimmune

involved in (1)

HDAC→mitochondrial_dysfunction

modulates (1)

HDAC→chromatin architecture

participates in (2)

HDAC→epigenetic regulationHDAC→oxidative stress response

regulates (5)

HDAC→gene transcriptionHDAC→NF-κBDNMT→gene promoter methylationHDAC→HuntingtonHDAC→Parkinson

targets (1)

h-8fe389e8→HDAC

therapeutic target (5)

HDAC→HDAC inhibitorsHDAC→MsHDAC→AlzheimerHDAC→AlsHDAC→Tumor

treats (1)

HDAC→Alzheimer's disease

🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps